Trial Profile
A Multi-Center, Phase 3b, Stratified, Randomized, Open-Label Clinical Trial to Evaluate the Efficacy of Intensive Apidra/Lantus Therapy vs Sliding Scale Insulin on Infarct Size in Hyperglycemic Subjects With Anterior STEMI (ST Elevation Myocardial Infarction) Undergoing PCI (Percutaneous Coronary Intervention).
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Insulin glulisine (Primary) ; Insulin
- Indications Hyperglycaemia; Myocardial infarction
- Focus Pharmacodynamics
- Acronyms INTENSIVE
- Sponsors Sanofi
- 22 Jan 2010 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 15 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jan 2010 Actual end date (Nov 2009) and actual number of patients (34) added as reported by ClinicalTrials.gov.